| Dr Joseph Yeretsian, MD | |
|
361 Newbury St Fl 5, Boston, MA 02115-2727 | |
| (617) 865-4910 | |
| (617) 507-1426 |
| Full Name | Dr Joseph Yeretsian |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 361 Newbury St Fl 5, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003070210 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | DR.0056212 (Colorado) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 235819 (Massachusetts) | Primary |
| Entity Name | Joseph Yeretsian Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942668165 PECOS PAC ID: 5597893313 Enrollment ID: O20200318000673 |
News Archive
An international team of researchers led by scientists at the University of Birmingham, UK, developed a series of steps to follow that could harness AI and integrate the power of nanomaterials safely, sustainably and responsibly, into agricultural practices..
A selection of health policy stories from Massachusetts, California, Michigan, Texas, the District of Columbia, Pennsylvania, South Carolina and Tennessee.
Boehringer Ingelheim Pharma GmbH & Co. KG, an international research-driven pharma company, and Eurofins Medigenomix GmbH, a competence center for genetic analyses of the Eurofins Scientific Group, concluded a long-term service agreement in the area of DNA banking, as well as a master service agreement for pharmacogenetic and pharmacogenomic services. For DNA banking Eurofins Medigenomix is supporting operations of Boehringer Ingelheim's central DNA bank at Biberach an der Riss.
Roswell Park Cancer Institute researchers have developed an accurate, individualized post-operative survival calculator and integrated the technology into a mobile application compatible with smartphone technology for oncologists and patients diagnosed with colon cancer. Information about the calculator will be presented at the American Society of Clinical Oncology 51st Annual Meeting in Chicago.
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, today commented on a Special Notice published by the US Department of Health and Human Services (DHHS), Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA) on December 29, 2009.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Yeretsian, MD 361 Newbury St Fl 5, Boston, MA 02115-2727 Ph: (617) 865-4910 | Dr Joseph Yeretsian, MD 361 Newbury St Fl 5, Boston, MA 02115-2727 Ph: (617) 865-4910 |
News Archive
An international team of researchers led by scientists at the University of Birmingham, UK, developed a series of steps to follow that could harness AI and integrate the power of nanomaterials safely, sustainably and responsibly, into agricultural practices..
A selection of health policy stories from Massachusetts, California, Michigan, Texas, the District of Columbia, Pennsylvania, South Carolina and Tennessee.
Boehringer Ingelheim Pharma GmbH & Co. KG, an international research-driven pharma company, and Eurofins Medigenomix GmbH, a competence center for genetic analyses of the Eurofins Scientific Group, concluded a long-term service agreement in the area of DNA banking, as well as a master service agreement for pharmacogenetic and pharmacogenomic services. For DNA banking Eurofins Medigenomix is supporting operations of Boehringer Ingelheim's central DNA bank at Biberach an der Riss.
Roswell Park Cancer Institute researchers have developed an accurate, individualized post-operative survival calculator and integrated the technology into a mobile application compatible with smartphone technology for oncologists and patients diagnosed with colon cancer. Information about the calculator will be presented at the American Society of Clinical Oncology 51st Annual Meeting in Chicago.
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, today commented on a Special Notice published by the US Department of Health and Human Services (DHHS), Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA) on December 29, 2009.
› Verified 5 days ago
Dr. Lee Edwin Goldstein, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 670 Albany St, Boston, MA 02118 Phone: 617-414-8361 Fax: 617-414-7073 | |
Dr. Michael Gulliver Erkkinen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 | |
Dr. Joseph Jeffrey Taylor, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 60 Fenwood Rd, Boston, MA 02115 Phone: 617-732-5500 | |
Sanjay Menon, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 55 Fruit St., Massachusetts General Hospital, Boston, MA 02114 Phone: 857-238-5600 | |
Lara Basovic, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 15 Parkman St Fl 8, Boston, MA 02114 Phone: 617-726-3311 Fax: 617-726-9250 | |
Ms. Ruth Farrell Mccann, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 |